Zibotentan, Dapagliflozin Combo Further Reduces Albuminuria in CKD

Hiddo Lambers Heerspink

Press/Media: Expert Comment › Popular

Period	8-Nov-2023 → 9-Nov-2023

Media contributions

2

Media contributions

Title	Zibotentan, Dapagliflozin Combo Further Reduces Albuminuria in CKD
Degree of recognition	International
Media name/outlet	Rheumatology Advisor
Media type	Web
Country/Territory	United States
Date	09/11/2023
URL	https://www.rheumatologyadvisor.com/general-medicine/zibotentan-dapagliflozin-combo-further-reduces-albuminuria-in-ckd/
Persons	Hiddo Lambers Heerspink

Title	Zibotentan, Dapagliflozin Combo Further Reduces Albuminuria in CKD
Degree of recognition	International
Media name/outlet	Renal and Urology News
Media type	Web
Country/Territory	United States
Date	08/11/2023
URL	https://www.renalandurologynews.com/conference-highlights/kidney-week-2023/zibotentan-dapagliflozin-combo-further-reduces-albuminuria-in-ckd/
Persons	Hiddo Lambers Heerspink